Millipore Sigma Vibrant Logo

MAB2500 Anti-Collagen Type VII Antibody, clone 32,-VII

View Products on Sigmaaldrich.com
MAB2500
100 µg  
Preis wird abgerufen...
Preis nicht abrufbar
Die Mindestmenge muss ein Vielfaches sein von
Maximum Quantity is
Bei Bestätigung Weitere Informationen
Sie haben () gespart
 
Bitte erfragen
Eingeschränkte Verfügbarkeit
Eingeschränkte Verfügbarkeit
Lieferbar 
Produkt wurde eingestellt
Begrenzter Lagerbestand
Bestätigung der Verfügbarkeit erforderlich
    Restmenge: Angebot folgt
      Restmenge: Angebot folgt
      Bitte erfragen
      Kontakt zum Kundenservice
      Contact Customer Service

      Sonderaktionen

       

      Kontakt zum Kundenservice

      Übersicht

      Replacement Information

      Key Spec Table

      Species ReactivityKey ApplicationsHostFormatAntibody Type
      B, HELISAMPurifiedMonoclonal Antibody
      Description
      Catalogue NumberMAB2500
      Brand Family Chemicon®
      Trade Name
      • Chemicon
      DescriptionAnti-Collagen Type VII Antibody, clone 32,-VII
      References
      Product Information
      FormatPurified
      PresentationLiquid at 1 mg/mL in 20 mM phosphate buffer, 250 mM NaCl, pH 7.6, containing 0.1% sodium azide.
      Quality LevelMQ100
      Applications
      ApplicationAnti-Collagen Type VII Antibody, clone 32, -VII detects level of Collagen Type VII & has been published & validated for use in ELISA.
      Key Applications
      • ELISA
      Application NotesELISA

      IH on unfixed, weakly fixed tissue sections.
      Biological Information
      Clone32, mAb-VII
      HostMouse
      SpecificityMonoclonal antibody MAB2500 recognizes human and bovine Type VII Collagen.
      IsotypeIgG1
      Species Reactivity
      • Bovine
      • Human
      Antibody TypeMonoclonal Antibody
      Entrez Gene Number
      Entrez Gene SummaryThis gene encodes the alpha chain of type VII collagen. The type VII collagen fibril, composed of three identical alpha collagen chains, is restricted to the basement zone beneath stratified squamous epithelia. It functions as an anchoring fibril between the external epithelia and the underlying stroma. Mutations in this gene are associated with all forms of dystrophic epidermolysis bullosa. In the absence of mutations, however, an acquired form of this disease can result from an autoimmune response made to type VII collagen.
      Gene Symbol
      • COL7A1
      • EBR1
      • EBD1
      • EBDCT
      UniProt Number
      UniProt SummaryFUNCTION: SwissProt: Q02388 # Stratified squamous epithelial basement membrane protein that forms anchoring fibrils which may contribute to epithelial basement membrane organization and adherence by interacting with extracellular matrix (ECM) proteins such as type IV collagen.
      SIZE: 2944 amino acids; 295220 Da
      SUBUNIT: Homotrimer.
      SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular matrix, basement membrane.
      PTM: Prolines at the third position of the tripeptide repeating unit (G-X-Y) are hydroxylated in some or all of the chains.
      DISEASE: SwissProt: Q02388 # Epidermolysis bullosa acquisita (EBA) is an autoimmune acquired blistering skin disease resulting from autoantibodies to type VII collagen. & Defects in COL7A1 are the cause of dystrophic epidermolysis bullosa (DEB) [MIM:131750, 226600]. DEB is a group of blistering skin diseases with either autosomal dominant or autosomal recessive inheritance. Ultrastructurally, DEB is characterized by tissue separation which occurs below the dermal- epidermal basement membrane at the level of the anchoring fibrils. Various clinical types with different severity are recognized. DEB Pasini type is a severe, dominantly inherited form. Among the recessively inherited forms, the Hallopeau-Siemens type epidermolysis bullosa is the most severe form. It manifests with mutilating scarring, joint contractures, corneal erosions, esophagus structures, and propensity to formation of cutaneous squamous cell carcinomas leading to premature demise of the affected individuals. Two milder recessive forms are dystrophic epidermolysis bullosa mitis type and the localized type. The mitis type shows lifelong blistering tendency, with limited scarring and less frequent extracutaneous manifestations. In the localized type, blistering and scarring are predominantly localized to the extremities. & Defects in COL7A1 are the cause of transient bullous dermolysis of the newborn (TBDN) [MIM:131705]. TBDN is a neonatal skin blistering disorder with features similar to those observed in dystrophic epidermolysis bullosa. TBDN is characterized by sub- epidermal blisters, reduced or abnormal anchoring fibrils at the dermo-epidermal junction, and electron-dense inclusions in keratinocytes. TBDN heals spontaneously or strongly improves within the first months and years of life. & Defects in COL7A1 are the cause of pretibial type dystrophic epidermolysis bullosa (P-DEB) [MIM:131850]. Inheritance is autosomal dominant. & Defects in COL7A1 are the cause of Bart type dystrophic epidermolysis bullosa (B-DEB) [MIM:132000]; also known as epidermolysis bullosa with congenital localized absence of skin and deformity of nails. Inheritance is autosomal dominant. & Defects in COL7A1 are the cause of epidermolysis bullosa pruriginosa (EBP) [MIM:604129]. EBP is a distinct clinical subtype of DEB. It is characterized by skin fragility, blistering, scar formation, intense pruritus and excoriated prurigo nodules. Onset is in early childhood, but in some cases is delayed until the second or third decade of life. Inheritance can be autosomal dominant or recessive. & Defects in COL7A1 are the cause of isolated toenail dystrophy without skin fragility [MIM:607523]. & Defects in COL7A1 are the cause of epidermolysis bullosa dystrophica with subcorneal cleavage (EBDSC) [MIM:607600]; also known as epidermolysis bullosa simplex superficialis (EBSS). EBDSC is a new variant of epidermolysis bullosa simplex (EBS), characterized by the development of skin cleavage just beneath the level of stratum corneum. It appears to be transmitted as an autosomal dominant trait and differs from other autosomal dominant forms of EBS by the common findings of milia and atrophic scarring, as well as involvement of oral and/or ocular surfaces. It is further differentiated by the presence of blisters and the absence of spontaneous continual exfoliation or peeling.
      SIMILARITY: SwissProt: Q02388 ## Contains 1 BPTI/Kunitz inhibitor domain. & Contains 9 fibronectin type-III domains. & Contains 2 VWFA domains.
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Usage Statement
      • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
      Storage and Shipping Information
      Storage ConditionsMaintain refrigerated at 2-8°C in undiluted aliquots for up to 12 months.
      Packaging Information
      Material Size100 µg
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Bestellnummer GTIN
      MAB2500 04053252577246

      Documentation

      Anti-Collagen Type VII Antibody, clone 32,-VII SDB

      Titel

      Sicherheitsdatenblatt (SDB) 

      Anti-Collagen Type VII Antibody, clone 32,-VII Analysenzertifikate

      TitelChargennummer
      MOUSE ANTI COLLAGEN VII MONOCLONAL ANTIBODY - 2038277 2038277
      MOUSE ANTI COLLAGEN VII MONOCLONAL ANTIBODY - 2127810 2127810
      MOUSE ANTI COLLAGEN VII MONOCLONAL ANTIBODY - 2140047 2140047
      MOUSE ANTI COLLAGEN VII MONOCLONAL ANTIBODY - 2383547 2383547
      MOUSE ANTI COLLAGEN VII - 2561984 2561984
      MOUSE ANTI COLLAGEN VII - 3194690 3194690
      MOUSE ANTI COLLAGEN VII - 3218275 3218275
      MOUSE ANTI COLLAGEN VII - 3222656 3222656
      MOUSE ANTI COLLAGEN VII - 3234580 3234580
      MOUSE ANTI COLLAGEN VII - 3283663 3283663

      Literatur

      ÜbersichtAnwendungPub Med ID
      Control of somatic tissue differentiation by the long non-coding RNA TINCR.
      Kretz, M; Siprashvili, Z; Chu, C; Webster, DE; Zehnder, A; Qu, K; Lee, CS; Flockhart, RJ; Groff, AF; Chow, J; Johnston, D; Kim, GE; Spitale, RC; Flynn, RA; Zheng, GX; Aiyer, S; Raj, A; Rinn, JL; Chang, HY; Khavari, PA
      Nature  493  231-5  2013

      Abstract anzeigen
      23201690 23201690
      Laminin-511 and integrin beta-1 in hair follicle development and basal cell carcinoma formation.
      DeRouen, MC; Zhen, H; Tan, SH; Williams, S; Marinkovich, MP; Oro, AE
      BMC developmental biology  10  112  2009

      Abstract anzeigen Volltextartikel
      21067603 21067603
      The development and characterization of an in vitro model of psoriasis.
      Barker, CL; McHale, MT; Gillies, AK; Waller, J; Pearce, DM; Osborne, J; Hutchinson, PE; Smith, GM; Pringle, JH
      The Journal of investigative dermatology  123  892-901  2004

      Abstract anzeigen
      Immunohistochemistry15482477 15482477

      Verwandte Produkte & Anwendungen

      Related Products

      Bestellnummer Beschreibung  
      MAB1345 Anti-Collagen Type VII Antibody, CT, clone LH7.2 Preis & Verfügbarkeit

      Produktfamilien

      Kategorien

      Life Science Research > Antibodies and Assays > Primary Antibodies